FluoroPharma Medical, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of molecular imaging pharmaceuticals with initial applications in the area of cardiology in the United States. The company was founded in 2003 and is headquartered in Montclair, New Jersey.
FluoroPharma Medical reported revenue of $0 for fiscal year 2016, and net income of -$2.57 million.
Figures from company filings; latest fiscal year ended December 31, 2016.
No profile data available.